URMC / Labs / Beck Lab / Publications Recent Publications Bawany FNorthcott CABeck LAPigeon WR Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.; The journal of allergy and clinical immunology. In practice. 2020 Dec 12. Bawany FFranco AIBeck LA Dupilumab: One therapy to treat multiple atopic diseases.; JAAD case reports; Vol 6(11). 2020 Nov. Beck LASilverberg JISimpson ELYosipovitch GEckert LGuillemin IChen ZArdeleanu MPlaum SGraham NRuddy MPirozzi GGadkari A Dupilumab Significantly Improves Sleep Outcomes in Adult Patients with Atopic Dermatitis: Results from Five Randomized Clinical Trials.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2020 Aug 12. Paller ASSiegfried ECThaçi DWollenberg ACork MJArkwright PDGooderham MBeck LABoguniewicz MSher LWeisman JO'Malley JTPatel NHardin MGraham NMHRuddy MSun XDavis JDKamal MAKhokhar FAWeinreich DMYancopoulos GDBeazley BBansal AShumel B Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial.; Journal of the American Academy of Dermatology. 2020 Jun 20. Beck LAThaçi DDeleuran MBlauvelt ABissonnette Rde Bruin-Weller MHide MSher LHussain IChen ZKhokhar FABeazley BRuddy MPatel NGraham NMHArdeleanu MShumel B Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.; American journal of clinical dermatology. 2020 Jun 17. Wollenberg ABeck LABlauvelt ASimpson ELChen ZChen QShumel BKhokhar FAHultsch TRizova ERossi ABGraham NMHPirozzi GLu YArdeleanu M Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.; The British journal of dermatology; Vol 182(6). 2020 Jun. Moran MCBeck LARichardson CT A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.; The Journal of investigative dermatology; Vol 140(5). 2020 May. Simpson EBissonnette REichenfield LFGuttman EKing BSilverberg JIBeck LABieber TReich KKabashima KSeyger MSiegfried EStingl GFeldman SRMenter Avan de Kerkhof PYosipovitch GPaul CMartel PDubost-Brama AArmstrong JChavda RFrey SJoubert YMilutinovic MParneix ATeixeira HDLin CYSun LKlekotka PNickoloff BDutronc YMallbris LJanes JMDeLozier AMNunes FPaller AS The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.; Journal of the American Academy of Dermatology. 2020 Apr 25. Platts-Mills TAECommins SPBiedermann Tvan Hage MLevin MBeck LADiuk-Wasser MJappe UApostolovic DMinnicozzi MPlaut MWilson JM On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.; The Journal of allergy and clinical immunology; Vol 145(4). 2020 Apr. Wieser JKKuehn GJPrezzano JCCusick EHStiegler JDScott GALiesveld JLBeck LA Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment.; JAAD case reports; Vol 6(4). 2020 Apr. Guttman-Yassky EThaçi DPangan ALHong HCPapp KAReich KBeck LAMohamed MFOthman AAAnderson JKGu YTeixeira HDSilverberg JI Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial.; The Journal of allergy and clinical immunology; Vol 145(3). 2020 Mar. Bawany FBeck LAJärvinen KM Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.; The journal of allergy and clinical immunology. In practice; Vol 8(3). 2020 Mar. Simpson ELLacour JPSpelman LGalimberti REichenfield LFBissonnette RKing BAThyssen JPSilverberg JIBieber TKabashima KTsunemi YCostanzo AGuttman-Yassky EBeck LAJanes JMDeLozier AMGamalo MBrinker DRCardillo TNunes FPPaller ASWollenberg AReich K Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.; The British journal of dermatology. 2020 Jan 05. Worm MSimpson ELThaçi DBissonnette RLacour JPBeissert SKawashima MFerrándiz CSmith CHBeck LAChan KCChen ZAkinlade BHultsch TStaudinger HGadkari AEckert LDavis JDRajadhyaksha MGraham NMHPirozzi GStahl NYancopoulos GDArdeleanu M Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.; JAMA dermatology. 2019 Dec 26. Moran MCCahill MPBrewer MGYoshida TKnowlden SPerez-Nazario NSchlievert PMBeck LA Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients.; mSphere; Vol 4(6). 2019 Dec 11. Simpson ELPaller ASSiegfried ECBoguniewicz MSher LGooderham MJBeck LAGuttman-Yassky EPariser DBlauvelt AWeisman JLockshin BHultsch TZhang QKamal MADavis JDAkinlade BStaudinger HHamilton JDGraham NMHPirozzi GGadkari AEckert LStahl NYancopoulos GDRuddy MBansal A Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.; JAMA dermatology. 2019 Nov 06. Alexander HPaller ASTraidl-Hoffmann CBeck LADe Benedetto ADhar SGirolomoni GIrvine ADSpuls PSu JThyssen JPVestergaard CWerfel TWollenberg ADeleuran MFlohr C The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.; The British journal of dermatology. 2019 Nov 01. Matson CCBeck LARajasekaran SK Using Language That Reflects Who Is the Center of Our Care.; Academic medicine : journal of the Association of American Medical Colleges; Vol 94(9). 2019 Sep. Boorgula MPTaub MARafaels NDaya MCampbell MChavan SShetty ACheadle CBarkataki SFan JDavid GBeaty THRuczinski IHanifin JSchneider LCGallo RLPaller ASBeck LALeung DYMathias RABarnes KC Replicated methylation changes associated with eczema herpeticum and allergic response.; Clinical epigenetics; Vol 11(1). 2019 Aug 23. Brewer MGYoshida TKuo FIFridy SBeck LADe Benedetto A Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.; International journal of molecular sciences; Vol 20(17). 2019 Aug 21. Wollenberg ABeck LABlauvelt ASimpson ELChen ZChen QShumel BKhokhar FAHultsch TRizova ERossi ABGraham NMHPirozzi GLu YArdeleanu M Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).; The British journal of dermatology. 2019 Aug 13. Brewer MGAnderson EAPandya RPDe Benedetto AYoshida THilimire TAMartinez-Sobrido LBeck LAMiller BL Peptides Derived from the Tight Junction Protein, Claudin-1, Disrupt Skin Barrier and Promote Responsiveness to an Epicutaneous Vaccine.; The Journal of investigative dermatology. 2019 Aug 02. Deleuran MThaçi DBeck LAde Bruin-Weller MBlauvelt AForman SBissonnette RReich KSoong WHussain IFoley PHide MBouaziz JDGelfand JMSher LSchuttelaar MLAWang CChen ZAkinlade BGadkari AEckert LDavis JDRajadhyaksha MStaudinger HGraham NMHPirozzi GArdeleanu M Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study.; Journal of the American Academy of Dermatology. 2019 Jul 30. Johnson BBBeck LAMustafa SS Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis.; JAAD case reports; Vol 5(7). 2019 Jul. Eichenfield LFBieber TBeck LASimpson ELThaçi Dde Bruin-Weller MDeleuran MSilverberg JIFerrandiz CFölster-Holst RChen ZGraham NMHPirozzi GAkinlade BYancopoulos GDArdeleanu M Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis.; American journal of clinical dermatology; Vol 20(3). 2019 Jun. Calvert JSGrahn PJStrommen JALavrov IABeck LAGill MLLinde MBBrown DAVan Straaten MGVeith DDLopez CSayenko DGGerasimenko YPEdgerton VRZhao KDLee KH Electrophysiological Guidance of Epidural Electrode Array Implantation over the Human Lumbosacral Spinal Cord to Enable Motor Function after Chronic Paralysis.; Journal of neurotrauma; Vol 36(9). 2019 May 01. Davidson WFLeung DYMBeck LABerin CMBoguniewicz MBusse WWChatila TAGeha RSGern JEGuttman-Yassky EIrvine ADKim BSKong HHLack GNadeau KCSchwaninger JSimpson ASimpson ELSpergel JMTogias AWahn UWood RAWoodfolk JAZiegler SFPlaut M Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions".; The Journal of allergy and clinical immunology; Vol 143(3). 2019 Mar. Lebwohl MAlexis AFBeck LABlock JKEichenfield LFFonacier LGuttman-Yassky EPaller ASPariser DSilverberg JIBoguniewicz M Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice; Journal of drugs in dermatology : JDD; Vol 18(2). 2019 Feb 01. Pietromonaco PRBeck LA Adult attachment and physical health.; Current opinion in psychology; Vol 25. 2019 Feb. Soh JMMercurio MGBeck LA Parental decisions for adolescent patients: Ethical considerations of information withholding.; Journal of the American Academy of Dermatology; Vol 80(1). 2019 Jan. Shah PRScott GBeck LA Image Gallery: Hairy-cell leukaemia presenting with Sweet syndrome.; The British journal of dermatology; Vol 180(1). 2019 Jan. Johnson BBFranco AIBeck LAPrezzano JC Treatment-resistant atopic dermatitis: challenges and solutions.; Clinical, cosmetic and investigational dermatology; Vol 12. 2019. Gill MLGrahn PJCalvert JSLinde MBLavrov IAStrommen JABeck LASayenko DGVan Straaten MGDrubach DIVeith DDThoreson ARLopez CGerasimenko YPEdgerton VRLee KHZhao KD Publisher Correction: Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia.; Nature medicine; Vol 24(12). 2018 Dec. Kwon CWBeck LA Severe atopic dermatitis: Therapeutic update.; Allergy and asthma proceedings; Vol 39(6). 2018 Nov 01. Garlanger KLBeck LACheville AL Functional outcomes in patients with co-occurring traumatic brain injury and spinal cord injury from an inpatient rehabilitation facility's perspective.; The journal of spinal cord medicine; Vol 41(6). 2018 Nov. An YAdams JRHollern DPZhao AChang SGGams MSChung PEDHe XJangra RShah JSYang JBeck LARaghuram NKozma KJLoch AJWang WFan CDone SJZacksenhaus EGuidos CJPerou CMEgan SE Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.; Cell reports; Vol 25(3). 2018 Oct 16. Pittelkow TPBendel MALueders DRBeck LAPingree MJHoelzer BC Title: Quantifying the change of spasticity after intrathecal baclofen administration: A descriptive retrospective analysis.; Clinical neurology and neurosurgery; Vol 171. 2018 Aug. Ke XKavati AWertz DHuang QWang LWilley VJStephenson JJOrtiz BPaknis BBernstein JABeck LA Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.; Journal of managed care & specialty pharmacy; Vol 24(7). 2018 Jul. Weidinger SBeck LABieber TKabashima KIrvine AD Atopic dermatitis.; Nature reviews. Disease primers; Vol 4(1). 2018 Jun 21. Lipof JSBeck LAReddy SCSouthgate RDCarney-Young KHammert WC Necrotizing Sweet Syndrome of the Upper Extremity After Elective Hand Surgery.; The Journal of hand surgery; Vol 43(4). 2018 Apr. Simpson ELVillarreal MJepson BRafaels NDavid GHanifin JTaylor PBoguniewicz MYoshida TDe Benedetto ABarnes KCLeung DYMBeck LA Atopic dermatitis Subjects Colonized with Staphylococcus aureus have a Distinct Phenotype and Endotype.; The Journal of investigative dermatology. 2018 Mar 28. Wang LKe XKavati AWertz DHuang QWilley VJStephenson JJOrtiz BPaknis BBernstein JABeck LA Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria.; Current medical research and opinion; Vol 34(1). 2018 Jan. Gill MLGrahn PJCalvert JSLinde MBLavrov IAStrommen JABeck LASayenko DGVan Straaten MGDrubach DIVeith DDThoreson ARLopez CGerasimenko YPEdgerton VRLee KHZhao KD Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia.; Nature medicine; Vol 24(11). 2018 Jan. Fingrut WBeck LALo D Building an oncology community of practice to improve cancer care.; Current oncology (Toronto, Ont.); Vol 25(6). 2018 Jan. Fingrut WBeck LALo D Oncology communities of practice: insights from a qualitative analysis.; Current oncology (Toronto, Ont.); Vol 25(6). 2018 Jan. Ke XKavati AWertz DHuang QWang LWilley VJStephenson JJOrtiz BPaknis BBernstein JABeck LA Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.; Journal of managed care & specialty pharmacy. 2017 Dec 19. Boguniewicz MAlexis AFBeck LABlock JEichenfield LFFonacier LGuttman-Yassky EPaller ASPariser DSilverberg JILebwohl M Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.; The journal of allergy and clinical immunology. In practice; Vol 5(6). 2017 Nov. Finlay AYKaplan APBeck LAAntonova ENBalp MMZazzali JKhalil SMaurer M Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.; Journal of the European Academy of Dermatology and Venereology : JEADV; Vol 31(10). 2017 Oct. Beck LA High Expectations.; The journal of spinal cord medicine; Vol 40(5). 2017 Sep. Prezzano JCBeck LA Long-Term Treatment of Atopic Dermatitis.; Dermatologic clinics; Vol 35(3). 2017 Jul.